Navigation Links
Sea Buckthorn Leaves May Hold Benefit for the Liver
Date:5/23/2008

High levels of antioxidants in berries also lower cholesterol, study says

FRIDAY, May 23 (HealthDay News) -- Sea buckthorn leaves are rich in antioxidants and may help protect against liver damage, according to a study by researchers in India.

The berries of the plant -- indigenous to the mountainous regions of China and Russia -- are already well known for their high levels of antioxidants and cholesterol-lowering properties, according to background information in the study.

In this study, the researchers examined whether sea buckthorn leaf extract could protect rats against liver damage.

The rats were divided into six groups: Group one was given a daily dose of saline for five days; group two received saline for four days and on the fifth day received a liver-damaging agent called carbon tetrachloride (CCI4); group three received a daily dose of silymarin for five days followed by a single dose of CCI4; groups four, five and six received 50, 100 and 200 milligrams of sea buckthorn leaf extract, respectively, for five days followed by a single dose of CCI4.

Rats that received CCI4 but no leaf extract suffered significant liver damage compared to the rats that didn't receive CCI4. But liver damage was greatly reduced in the rats that received the 100- and 200-milligram doses of leaf extract and CCI4.

The study was published in the current issue of the Journal of the Science of Food and Agriculture.

More information

The U.S. National Library of Medicine has more on liver diseases.



-- Robert Preidt



SOURCE: The Society of Chemical Industry, news release, May 23, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. New discovery leaves blood-doping athletes scratching their heads
2. New discovery leaves blood-doping athletes scratching their heads
3. Obesity Leaves More Americans With Physical Limitations
4. Europes Columbus laboratory leaves Earth
5. Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations
6. Federal Health Plan for Children Still Leaves Needs Unmet
7. Miracle leaves that may help protect against liver damage
8. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
9. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
10. Discovery of sugar sensor in intestine could benefit diabetes
11. Study shines more light on benefit of vitamin D in fighting cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Karlstad University in Sweden shows that phthalates from PVC ... are substances suspected to cause asthma and allergies, as ... shows that children can ingest these softening agents with ... , Phthalates are a group of chemical compounds that ... common consumer goods such as toys, cleaning solvents, packaging, ...
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... the United Kingdom have determined that azithromycin, a ... be an effective treatment option for patients suffering ... that occurs in the majority of patients following ... cause of mortality after the first year following ... repeatedly rejects the transplanted lung tissue. The syndrome ...
(Date:5/22/2012)... for determining effectiveness of medical therapies, tests and ... studies compared with other western countries, states an ... Association Journal ). , Dr. Salim Yusuf, McMaster ... Dr. John Cairns, University of British Columbia, argue ... provide better financial support of clinical trials and ...
(Date:5/22/2012)... began last year when the U.S. Preventive Services Task ... prostate-cancer tests to healthy men continued this week when ... stuck to their guns, stating that a blood test ... test, causes more harm than good it leads ... , But many people simply don,t believe that the ...
Breaking Medicine News(10 mins):Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Psychological Science explains uproar over prostate-cancer screenings 2
... living microorganisms that have beneficial effects on human health, ... a diverse range of disorders. However, the ways in ... fully understood. One of the action mechanisms could be ... and adaptive immune responses. At present there is only ...
... a common clinical encounter. Complications of this pathology are ... of the foreign body, the presence of a perforation, ... the University Medical Center of Grenoble advocates the use ... the proximal tip of the foreign body where it ...
... Uterine Fibroid Embolization, WASHINGTON, March 18 ... interventional radiology treatment,for uterine fibroids, provides significant ... (FUS) treatment failed, according to a study,released ... 33rd Annual,Scientific Meeting in Washington, D.C. Primary ...
... Successfully Treats, Graft-Versus-Host Disease, WASHINGTON, March ... (GVHD) after bone marrow or cord blood,transplant is ... it is not always effective and failure results ... 15 patients who failed standard,treatment were given a ...
... A study presented today,at the Society of Interventional ... in the Atlanta metro area, only 18 percent ... were told about uterine,fibroid embolization (UFE), a minimally ... UFE is a safe, effective,established treatment that has ...
... Greenhill & Co., Inc.,(NYSE: GHL ), a leading ... join the Firm as a Managing Director. Mr.,Giaquinto, who ... Care,Group at Citigroup Global Markets, will focus on the ... 18 years covering health care companies as an,investment banker, ...
Other Medicine News:Health News:Do bacterial combinations result in enhanced cytokine production? No! 2Health News:What should we do when esophageal perforation occurs? 2Health News:UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed 2Health News:UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed 3Health News:New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants 2Health News:New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants 3Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 2Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 3Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 4
(Date:5/23/2012)... -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today ... U.S. phase 2 clinical trial, T reatment with ... reater E fficacy T rial (TARGET-NTM), ... with non-tuberculous mycobacterial (NTM) lung disease. ... current NTM treatment recommendations, and no new drugs have ...
(Date:5/23/2012)... TriReme Medical, Inc. (TMI) today announced approval by the ... PTCA Catheter, indicated for treating the stenotic portion of ... Glider™ is the world,s only torqueable PTCA ... tip technology, Glider™ is designed to perform, even in ... an ultra short balloon length of 4mm designed for ...
(Date:5/23/2012)... Reportlinker.com announces that a new ... catalogue: Pharmaceuticals - ... http://www.reportlinker.com/p0191857/Pharmaceuticals---Global-Group-of-Eight-G8-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu ... Industry Guide is an essential resource for ... industry in each of the G8 (United ...
Breaking Medicine Technology:Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter 2Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2Pharmaceuticals - Global Group of Eight (G8) Industry Guide 3Pharmaceuticals - Global Group of Eight (G8) Industry Guide 4Pharmaceuticals - Global Group of Eight (G8) Industry Guide 5Pharmaceuticals - Global Group of Eight (G8) Industry Guide 6Pharmaceuticals - Global Group of Eight (G8) Industry Guide 7Pharmaceuticals - Global Group of Eight (G8) Industry Guide 8Pharmaceuticals - Global Group of Eight (G8) Industry Guide 9Pharmaceuticals - Global Group of Eight (G8) Industry Guide 10Pharmaceuticals - Global Group of Eight (G8) Industry Guide 11Pharmaceuticals - Global Group of Eight (G8) Industry Guide 12Pharmaceuticals - Global Group of Eight (G8) Industry Guide 13Pharmaceuticals - Global Group of Eight (G8) Industry Guide 14Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 1Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 1Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 2Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 3
Inquire...
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
Medicine Products: